Original articles

• The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System

  Antonio Fernández-Ortiz, Marian Cristina Bas Villalobos, María García-Márquez, José Luis Bernal Sobrino, Cristina Fernández-Pérez, Náyade del Prado González, Ana Viana Tejedor, Iván Núñez-Gil, Carlos Macaya Miguel, Francisco Javier Elola Somoza

  Rev Esp Cardiol. 2022;75:756-62

• Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers

  Rocío Eiros, Manuel Barreiro-Pérez, Ana Martín-García, Julia Almeida, Eduardo Villacorta, Alba Pérez-Pons, Soraya Merchán, Alba Torres-Valle, Clara Sánchez-Pablo, David González-Calle, Oihane Pérez-Escurza, Inés Toranzo, Elena Díaz-Peláez, Blanca Fuentes-Herrero, Laura Macías-Álvarez, Guillermo Oliva-Ariza, Quentin Lecrevisse, Rafael Fluxa, José L. Bravo-Grande, Alberto Orfao, Pedro L. Sánchez, on behalf of the CCC (cardiac COVID-19 healthcare workers) investigators

  Rev Esp Cardiol. 2022;75:734-46

• Clinical findings associated with incomplete hemodynamic left ventricular unloading in patients with a left ventricular assist device

  María J. Ruiz-Cano, René Schramm, Lech Paluszkiewicz, Lilit Ramazyan, Sebastián V. Rojas, Volker Lauenroth, Adriana Krenz, Jan Gummert, Michiel Morshuis

  Rev Esp Cardiol. 2022;75:626-35

• Gender differences in drug titration among heart failure patients with reduced ejection fraction in the ETIFIC trial

  Juana Oyanguren, Beatriz Díaz-Molina, Iñaki Lekuona, José González-Costello, Silvia López-Fernández, José M. García-Pinilla, Lluisa Garcia-Garrido, Gracia López-Moyano, Nicolás Manito, Marta Cobo-Marcos, Magdalena Nebot-Margalef, Pedro Latorre-García, Eunate Arana-Arri, Silvia Pérez-Fernández, Jesús Torcal-Laguna, on behalf of the ETIFIC research team group

  Rev Esp Cardiol. 2022;75:636-48

• Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study

  Miguel Ruiz-Canela, Marta Guasch-Ferré, Cristina Razquin, Estefanía Toledo, Pablo Hernández-Alonso, Clary B. Clish, Jun Li, Clemens Wittenbecher, Courtney Dennis, Ángel Alonso-Gómez, Enrique Almanza-Aguilera, Liming Liang, Dolores Corella, Enrique Gómez-Gracia, Ramón Estruch, Miguel Fiol, José Lapetra, Lluis Serra-Majem, Emilio Ros, Fernando Arós, Jordi Salas-Salvadó, Frank B. Hu, Miguel Ángel Martínez-González

  Rev Esp Cardiol. 2022;75:649-58

• Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry

  Oriol Rodríguez-Leor, Ana Belén Cid-Álvarez, Armando Pérez de Prado, Xavier Rosselló, Soledad Ojeda, Ana Serrador, Ramón López-Palop, Javier Martín-Moreiras, José Ramón Rumoroso, Ángel Cequier, Borja Ibáñez, Ignacio Cruz-González, Rafael Romaguera, Sergio Raposeiras, Raúl Moreno, on behalf of the investigators of the Infarction Code Working Group of the Interventional Cardiology Association of the Spanish Society of Cardiology

  Rev Esp Cardiol. 2022;75:669-80

• Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes

  Aida Ribera, Josep R. Marsal, María T. Faixedas, Alba Rosas, Helena Tizón-Marcos, Sergio Rojas, Carlos Labata, Mérida Cárdenas, Silvia Homs, Carlos Tomás-Querol, Joan García-Picart, Gerard Roura, Mónica Masotti, Josepa Mauri, José Ignacio Pijoan, José A. Barrabés, Ignacio Ferreira-González, on behalf of the Codi IAM Investigators

  Rev Esp Cardiol. 2022;75:659-68

• Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

  Moisés Rodríguez-Mañero, Aurora Baluja, Jaime Hernández, Carmen Muñoz, David Calvo, Juan Fernández-Armenta, Amaya García-Fernández, Esther Zorio, Álvaro Arce-León, Juan Miguel Sánchez-Gómez, Ignacio Mosquera-Pérez, Miguel Á. Arias, Ernesto Díaz-Infante, Víctor Expósito, Víctor Jiménez-Ramos, Elvis Teijeira, María Victoria Cañadas-Godoy, José María Guerra-Ramos, Teresa Oloriz, Nuria Basterra, Pedro Sousa, Juliana Elices-Teja, Ignacio García-Bolao, José Ramón González-Juanatey, Ramón Brugada, Juan Ramón Gimeno, Josep Brugada, Elena Arbelo

  Rev Esp Cardiol. 2022;75:559-67

• Long-term recurrences and mortality in patients with noncardiac syncope

  Gonzalo Barón-Esquivias, Macarena Quintanilla, Antonio J. Díaz-Martín, Carmen Barón-Solís, Carmen V. Almeida-González, Carmen García-Romero, Inmaculada Paneque, Carmen Rubio-Guerrero, Rosario Rodríguez-Corredor, Juan I. Valle-Racero, Antonio Ordóñez, Carlos A. Morillo

  Rev Esp Cardiol. 2022;75:568-75

• The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients

  Héctor Bueno, José L. Bernal, Víctor Jiménez-Jiménez, Francisco Javier Martín-Sánchez, Xavier Rossello, Guillermo Moreno, Clara Goñi, Víctor Gil, Pere Llorens, Nerea Naranjo, Javier Jacob, Pablo Herrero-Puente, Sergio Garrote, Juan Carlos Silla-Castro, Stuart J. Pocock, Òscar Miró, the ICA-SEMES ad hoc COHERENT study group

  Rev Esp Cardiol. 2022;75:585-94

• Lactate levels as a prognostic predict in cardiogenic shock under venoarterial extracorporeal membrane oxygenation support

  Jorge Martínez-Solano, Iago Sousa-Casasnovas, José María Bellón-Cano, Jorge García-Carreño, Miriam Juárez-Fernández, Felipe Díez-Delhoyo, Ricardo Sanz-Ruiz, Carolina Devesa-Cordero, Jaime Elízaga-Corrales, Francisco Fernández-Avilés, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2022;75:595-603

• Aortic events in pregnant patients with Marfan syndrome. Lessons from a multicenter study

  Carlos E. Martín, Arturo Evangelista, Gisella Teixidó, Susana Villar, Santiago Serrano-Fiz, Víctor Ospina, Susana Mingo, Vanessa Moñivas, Daniel Martínez, Juan Villarreal, Alberto Forteza

  Rev Esp Cardiol. 2022;75:552-8

• Lifestyle and cardiovascular mortality in menopausal women: a population-based cohort study

  José A. Quesada, Vicente Bertomeu-González, Juan M. Ruiz-Nodar, Adriana López-Pineda, Francisco Sánchez-Ferrer

  Rev Esp Cardiol. 2022;75:576-84

• Characterization of hereditary transthyretin cardiac amyloidosis in Spain

  Jorge Álvarez Rubio, Ana José Manovel Sánchez, José González-Costello, Pablo García-Pavía, Javier Limeres Freire, José Manuel García-Pinilla, Esther Zorio Grima, Ana García-Álvarez, María Valverde Gómez, M. Ángeles Espinosa Castro, Gonzalo Barge-Caballero, Juan Ramón Gimeno Blanes, María Teresa Bosch Rovira, Luis Miguel Rincón Díaz, Miguel Ángel Aibar Arregui, María Gallego-Delgado, Juan Jiménez-Jáimez, Marina Martínez Moreno, Mayte Basurte, Xabier Arana Achaga, Idaira Famara Hernández Baldomero, Tomás Ripoll-Vera, on behalf of the AC-TTRv-Spain Investigator Group

  Rev Esp Cardiol. 2022;75:488-95

• Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018

  Jaime Díaz-Guzmán, Román Freixa-Pamias, Javier García-Alegría, Alejandro-Isidoro Pérez Cabeza, Inmaculada Roldán-Rabadán, Beatriz Antolin-Fontes, Pablo Rebollo, Aleix Llorac, Mar Genís-Gironés, Carlos Escobar-Cervantes

  Rev Esp Cardiol. 2022;75:496-505

• Quantitative flow ratio for evaluation of borderline coronary lesions in patients with severe aortic stenosis

  Pawel Kleczynski, Artur Dziewierz, Lukasz Rzeszutko, Dariusz Dudek, Jacek Legutko

  Rev Esp Cardiol. 2022;75:472-8

• Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

  Pilar Jiménez-Quevedo, Luis Nombela-Franco, Erika Muñoz-García, Raquel del Valle-Fernández, Ramiro Trillo, José M. de la Torre Hernández, Luisa Salido, Jaime Elizaga, Soledad Ojeda, Joaquín Sánchez Gila, Bruno García del Blanco, Alberto Berenguer, Garikoit Lasa-Larraya, Cristóbal Urbano Carrillo, Agustín Albarrán, Rafael Ruiz-Salmerón, José Moreu, Livia Gheorghe, Dabit Arzamendi, Geoffrey Yanes-Bowden, José Díaz, Ignacio Pérez-Moreiras, Miguel Artaiz, Beatriz Vaquerizo, Ignacio Cruz-González, Valeriano Ruiz-Quevedo, Roberto Blanco-Mata, José Antonio Baz, Manuel Villa, Álvaro Ortiz de Salazar, Valentín Tascón-Quevedo, Sandra Casellas, Raúl Moreno

  Rev Esp Cardiol. 2022;75:479-87

• Impact of lipid-lowering therapies on cardiovascular outcomes according to coronary artery calcium score. A systematic review and meta-analysis

  Guglielmo Gallone, Edoardo Elia, Francesco Bruno, Filippo Angelini, Luca Franchin, Pier Paolo Bocchino, Francesco Piroli, Umberto Annone, Andrea Montabone, Giorgio Marengo, Maurizio Bertaina, Ovidio De Filippo, Luca Baldetti, Anna Palmisano, Alessandro Serafini, Antonio Esposito, Alessandro Depaoli, Fabrizio D’ascenzo, Paolo Fonio, Gaetano Maria De Ferrari

  Rev Esp Cardiol. 2022;75:506-14

• Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial

  Fernando Alfonso, José M. de la Torre Hernández, Borja Ibáñez, Manel Sabaté, Manuel Pan, Rajiv Gulati, Jacqueline Saw, Dominick J. Angiolillo, David Adlam, Francisco Sánchez-Madrid

  Rev Esp Cardiol. 2022;75:515-22

• Left atrial enlargement in competitive athletes and atrial electrophysiology

  Cristian Herrera, Vanesa Bruña, Agustí Comella, Alejandro de la Rosa, Leonel Díaz-González, Martín Ruiz-Ortiz, Juan Lacalzada-Almeida, Alejandro Lucía, Araceli Boraita, Antonio Bayés-de-Luna, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2022;75:421-8